Antiplatelet Antibodies in Chronic Immune Thrombocytopenia and Their Role in Platelet Destruction and Defective Platelet Production

Hematology/Oncology Clinics of North America

Volumn 23, Issue 6, 2009, Pages 1163-1175

  McMillan, Robert ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Autoantibody; Autoimmune; Immune thrombocytopenia; Thrombocytopenia

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; FIBRINOGEN RECEPTOR; GROWTH FACTOR; THROMBIN RECEPTOR; THROMBOCYTE ANTIBODY; THROMBOPOIETIN;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL MATURATION; CHO CELL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOASSAY; IN VITRO STUDY; MEASUREMENT; MEGAKARYOCYTE; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; REMISSION; REVIEW; SENSITIVITY AND SPECIFICITY; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

AUTOANTIBODIES; BLOOD PLATELETS; CHRONIC DISEASE; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 70449669099     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.08.008     Document Type: Review

References (59)

1. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 (1996) 3-40
2. Harrington W.J., Sprague C.C., Minnich V., et al. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 38 (1953) 433-469
3. Shulman N.R., Marder V.J., and Weinrach R.S. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic, and isotopic studies. Ann NY Acad Sci 124 (1965) 499-542
4. Kelton J.G., Powers P.J., and Carter C.J. A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood 60 (1982) 1050-1053
5. Mueller-Eckhardt C., Kayser W., Mersch-Baumert K., et al. The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. Br J Haematol 46 (1980) 123-131
6. van Leeuwen E.F., van der Ven J.T.H., Engelfriet C.P., et al. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 59 (1982) 23-26
7. McMillan R., Tani P., Millard F., et al. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 70 (1987) 1040-1045
8. Kiefel V., Santoso S., Weisheit M., et al. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70 (1987) 1722-1726
9. Brighton T.A., Evans S., Castaldi P.A., et al. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 88 (1996) 194-201
10. Warner M.N., Moore J.C., Warkentin T.E., et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 104 (1999) 442-447
11. McMillan R., Wang L., and Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 1 (2003) 485-491
12. Fujisawa K., Tani P., Piro L., et al. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 81 (1993) 2872-2877
13. Olsson B., Andersson P., Jernas M., et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 9 (2003) 1123-1124
14. Fabris F., Scandellari R., Ruzzon E., et al. Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura. Blood 103 (2004) 4562-4564
15. Varon D., and Karpatkin S. A monoclonal antiplatelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. Proc Natl Acad Sci U S A 80 (1983) 6992-6995
16. Hou M., Stockelberg D., Kutti J., et al. Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombcytopenic purpura. Br J Haematol 91 (1995) 971-975
17. Escher R., Muller D., Vogel M., et al. Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP. Br J Haematol 102 (1998) 820-828
18. Nugent D.J. Human monoclonal antibodies in the characterization of platelet antigens. In: Kunicki T., and George J.N. (Eds). Platelet immunobiology: molecular and clinical aspects (1989), Lippincott, Philadelphia 273-290
19. He R., Reid D.M., Jones C.E., et al. Extracellular epitopes of platelet glycoprotein Iba reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura. Blood 86 (1995) 3789-3796
20. McMillan R., Lopez-Dee J., and Bowditch R. Clonal restriction of platelet-associated anti-GPIIb/IIIa autoantibodies in patients with chronic ITP. Thromb Haemost 85 (2001) 821-823
21. Roark J.H., Bussel J.B., Cines D.B., et al. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood 100 (2002) 1388-1398
22. Fujisawa K., and McMillan R. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens. Blood 81 (1993) 1284-1289
23. Kosugi S., Tomiyama Y., Shiraga M., et al. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies. Thromb Haemost 75 (1996) 339-345
24. Bowditch R.D., Tani P., and McMillan R. Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides. Br J Haematol 91 (1995) 178-184
25. McMillan R., Lopez-Dee J., and Loftus J.C. Autoantibodies to aIIbb3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on aIIb. Blood 97 (2001) 2171-2172
26. Tomiyama Y., Kurata Y., Mizutani H., et al. Platelet glycoprotein IIb as a target antigen in two patients with chronic immune thrombocytopenic purpura. Br J Haematol 66 (1987) 535-538
27. McMillan R., Wang L., Lopez-Dee J., et al. Many aIIbb3 autoepitopes are localized to aIIb between amino acids L1 and Q459. Br J Haematol 118 (2002) 1132-1136
28. Kosugi S., Tomiyama Y., Honda S., et al. Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of GPIIb. Blood 98 (2001) 1819-1827
29. Askonas B.A., and Humphrey J.H. Formation of specific antibodies and g-globulin in vitro: a study of the synthetic ability of various tissues from rabbits immunized by different methods. Biochem J 68 (1958) 252-261
30. McMillan R., Longmire R.L., Yelenosky R., et al. Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura. N Engl J Med 286 (1972) 681-684
31. Karpatkin S., Strick N., and Siskind G.W. Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol 23 (1972) 167-176
32. McMillan R., Longmire R.L., Yelenosky R., et al. Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura. N Engl J Med 291 (1974) 812-817
33. McMillan R., Luiken G.A., Levy R., et al. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 239 (1978) 2460-2462
34. McMillan R., Yelenosky R.J., and Longmire R.L. Antiplatelet antibody production by the spleen and bone marrow in immune thrombocytopenic purpura. In: Battisto J.R., and Streinlein J.W. (Eds). Immunoaspects of the spleen (1976), North Holland Biomedical Press, Amsterdam 227-237
35. Harker L.A. Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol 19 (1970) 95-104
36. Branehog I., Kutti J., and Weinfeld A. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol 27 (1974) 127-143
37. Stoll D., Cines D.B., Aster R.H., et al. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 65 (1985) 584-588
38. Heyns A.P., Badenhorst P.N., Lotter M.G., et al. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111-In-labeled and homologous 51- Cr-labeled platelets differ. Blood 67 (1986) 86-92
39. Ballem P.J., Segal G.M., Stratton J.R., et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence for both impaired platelet production and increased platelet clearance. J Clin Invest 80 (1987) 33-40
40. Handin R.I., and Stossel T.P. Phagocytosis of antibody-coated platelets by human granulocytes. N Engl J Med 290 (1974) 989-993
41. Zucker-Franklin D., and Karpatkin S. Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. N Engl J Med 297 (1977) 517-523
42. McMillan R., Longmire R.L., Tavassoli M., et al. In vitro platelet phagocytosis by ITP splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med 290 (1974) 249-251
43. Tsubakio T., Kurata Y., Kanayama Y., et al. In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura. Acta Haematol 70 (1983) 250-256
44. Shulman N.R., Weinrach R.S., Libre E.P., et al. The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physicians 78 (1965) 374-390
45. Clarkson S.B., Bussel J.B., Kimberly R.P., et al. Treatment of refractory immune thrombocytopenic purpura with anti-Fcg-receptor antibody. N Engl J Med 314 (1986) 1236-1239
46. McMillan R., Bowditch R., Tani P., et al. A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb/III a autoantibody. Br J Haematol 95 (1996) 747-749
47. Hauch T.W., and Rosse W.F. Platelet-bound complement (C3) in immune thrombocytopenia. Blood 50 (1977) 1129-1136
48. Kurata Y., Curd J.G., Tamerius J.D., et al. Platelet-associated complement in chronic ITP. Br J Haematol 60 (1985) 723-733
49. McMillan R., and Martin M. Fixation of the third component of complement (C3) to platelets in vitro by antiplatelet antibody for patients with ITP. Br J Haematol 47 (1981) 251-256
50. Dameshek W., and Miller E.B. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood 1 (1946) 27-52
51. Pisciotta A.V., Stefanini M., and Dameshek W. Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood 8 (1953) 703-723
52. Diggs L.W., and Hewlett J.S. A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura. Blood 3 (1948) 1090-1104
53. Stahl C.P., Zucker-Franklin D., and McDonald T.P. Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood 67 (1986) 421-428
54. Houwerzijl E.J., Blom N.R., van der Want J.J.L., et al. Ultrastructural study shows morphological features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 103 (2004) 500-506
55. Heyns A.P., Lotter M.G., Badenhorst P.N., et al. Kinetics and sites of destruction of 111-Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Hematol 12 (1982) 167-177
56. McMillan R., Wang L., Tomer A., et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients. Blood 103 (2004) 1364-1369
57. Chang M., Nakagawa P.A., Williams S.A., et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102 (2003) 887-895
58. Bussel J.B., Kuter D.J., Pullarkat V., et al. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Lancet 113 (2009) 2161-2171
59. Bussel J.B., Provan D., Shamsi T., et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial. Lancet 373 (2009) 641-648